ORLANDO,
Fla., Feb. 13, 2025 /PRNewswire/
-- LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath,"
the "Company," or "we"), a leading provider of next-generation
optics and imaging systems for both defense and commercial
applications, today announced financial results for its fiscal 2025
second quarter ended December 31,
2024.
Financial Summary:
|
Three Months Ended
December 31,
|
|
$ in
millions
|
2024
|
2023
|
%
Change
|
Revenue
|
$7.4
|
$7.3
|
1.5 %
|
Gross
Profit
|
$1.9
|
$2.2
|
-11.0 %
|
Operating
Expenses
|
$4.4
|
$4.0
|
11.7 %
|
Net Income
(Loss)
|
($2.6)
|
($1.7)
|
52.4 %
|
EBITDA*
(non-GAAP)
|
($1.5)
|
($0.5)
|
228.9 %
|
Second Quarter Fiscal 2025 & Subsequent
Highlights:
- Announced the acquisition of G5 Infrared ("G5"), a leading
high-end infrared camera systems manufacturer, part
of LightPath's strategic vision to become a leading vertically
integrated infrared ("IR") imaging solutions provider, and
financing related to the transaction
- Began sustained delivery of infrared assemblies to a European
defense customer for active-duty use in First-Person View ("FPV")
drone applications
- Launched new optical gas imaging ("OGI") cameras, including:
- OGI cameras for ammonia and sulfur hexafluoride ("SF6")
detection at industrial and manufacturing facilities
- OGI cameras for detecting fugitive gas emissions for Oil &
Gas applications, launched at the CH4 Connections Conference
- Awarded Phase 2 funding in U.S. Defense Department partnership
to qualify additional BlackDiamond glasses as germanium
substitutes
- Participated in leading investor conferences including
the LD Micro Main Event, the 27th Annual Needham
Growth Conference and the Sequire Investor Summit Puerto Rico
Management Commentary
Sam Rubin, President and Chief
Executive Officer of LightPath, said: "The second quarter of fiscal
2025 was highlighted by the acquisition of G5 Infrared, marking a
significant step forward as part of our evolution towards becoming
a leading vertically integrated, global solutions provider for
infrared imaging technologies for defense and commercial
applications. G5 achieved preliminary unaudited calendar year 2024
revenues of more than $15 million and
we believe there is significant room for near-term growth on the
back of multiple programs of record and that we will benefit from
G5's higher-average selling price ("ASP") and high-margin cooled
infrared camera offering.
"G5 provides a highly incremental offering to LightPath,
providing a broad range of cooled infrared camera solutions and
assemblies, ranging from high performance mid wave zoom thermal
imaging camera systems to thin film deposition services on a
variety of infrared substrates, all of which are complimentary to
our line of uncooled infrared cameras, infrared optics and infrared
materials. The company has a significant pipeline of new business
opportunities, with multiple program awards expected to begin
production in the next two years. We believe that this will
drive a robust growth profile and margins that will aid us as we
pursue our long-term goal of 15% EBITDA margins at the corporate
level. We expect to add significant value beyond the immediately
accretive revenue stream and believe the acquisition will continue
to drive future growth with its higher ASPs, incremental products
and notable operational synergies – such as integrating their
offerings with our proprietary BlackDiamond™ glass and in-house
optics manufacturing capabilities.
"In the European market, during the quarter we received an
initial development contract from a new European defense customer
for the use of BlackDiamond glass in optical systems. We also began
sustained delivery of infrared lens assemblies per the terms of the
October 2024 Letter of Intent from a
European defense customer for active duty use in FPV drone
applications. This order highlights two exciting opportunities for
LightPath, making the most of our European Defense license acquired
last year, which positions us to supply products to one of the
largest defense markets in the world. The order also highlights the
growing use of drones and unmanned aerial vehicles for a variety of
defense applications, giving our proprietary BlackDiamond™
chalcogenide-based glass materials an opportunity to become an
important material for thermal cameras in these vehicles.
"We continued to expand our product portfolio and market
potential with the launch of our OGI camera platform, a specialized
technology utilizing IR cameras to detect and visualize emissions.
Our first variation for oil and gas applications is useful for
detecting methane, volatile organic compounds, hydrocarbons, and
other industrial gases that can be harmful to the environment or
human health. A second version was launched to detect fugitive
ammonia and SF6 emissions for industrial and manufacturing
applications. Not only are these cameras cost effective, highly
sensitive, and operational without proprietary software, but they
are also built with a non-germanium lens. This feature is becoming
increasingly important to customers looking for insulation from the
geopolitical supply chain issues plaguing competing Germanium based
solutions – such as China's recent
ban on the export of Germanium to the
United States. On December 4,
2024, China announced
further restrictions on export of Germanium to the U.S. altogether,
as well as for dual-use applications in other countries as well.
LightPath has been preparing for this day with the introduction of
our BlackDiamond materials, qualification of those materials
through our partnership with the U.S. Department of Defense –
Defense Logistics Agency, and working with customers to redesign
their systems to replace Germanium optics. Since China's announcement we have seen a growing
interest and demand in our BlackDiamond materials and are
encouraged to see customers begin the process to switch over to
those materials.
"As we move into calendar year 2025, we look forward to
integrating G5 into the LightPath family and benefiting from its
strong pipeline of new business opportunities in the government and
defense sectors. We also expect to move forward with key defense
programs, including our bid to produce a design of a major missile
program for the U.S. Army with Lockheed Martin. We are now starting
to deliver flightworthy hardware for implementation into Lockheed
Martin's initial live test units for this program, from which we
believe the U.S. Army could make a decision as early as later this
year. Taken together, we believe 2025 will build additional
momentum toward our vision of becoming a vertically integrated,
next-generation optics and imaging solutions provider," concluded
Rubin.
Second Quarter Fiscal 2025 Financial Results
Revenue for the second quarter of fiscal 2025 increased 1.5% to
$7.4 million, as compared to
$7.3 million in the same quarter of
the prior fiscal year. Revenue was split amongst the Company's
product groups in the second quarter of fiscal 2025 as follows:
Product Group
Revenue
($ in millions)**
|
Second Quarter
of
Fiscal 2025
|
Second Quarter
of
Fiscal 2024
|
%
Change
|
Infrared ("IR")
Components
|
$3.1
|
$3.6
|
-13 %
|
Visible
Components
|
$2.8
|
$2.7
|
3 %
|
Assemblies &
Modules
|
$0.9
|
$1.0
|
-13 %
|
Engineering
Services
|
$0.7
|
$0.1
|
797 %
|
** Numbers may not foot due to rounding
Gross profit decreased 11% to $1.9
million, or 26% of total revenues, in the second quarter of
2025, as compared to $2.2 million, or
30% of total revenues, in the same quarter of the prior fiscal
year. The decrease in gross margin as a percentage of revenue is
primarily due to differences in the product mix, coupled with some
manufacturing yield issues in infrared components.
Operating expenses increased 12% to $4.4
million for the second quarter of fiscal 2025, as compared
to $4.0 million in the same quarter
of the prior fiscal year. The increase was primarily due to higher
legal and consulting fees related to business development
initiatives, including expenses associated with the G5 acquisition
announced today, as well as increased sales and marketing spend to
promote new products and an increase in materials spend for
internally funded new product development projects.
Net loss in the second quarter of fiscal 2025 totaled
$2.6 million, or $0.07 per basic and diluted share, as compared to
$1.7 million, or $0.05 per basic and diluted share, in the same
quarter of the prior fiscal year. The increase in net loss was
primarily attributable to lower gross profit coupled with increased
SG&A and new product development costs, as well as higher
interest expense.
EBITDA* loss for the second quarter of fiscal 2025 was
$1.5 million, compared to a loss of
$0.5 million for the same period of
the prior fiscal year. The decrease in EBITDA in the second
quarter of fiscal 2025 was primarily attributable to lower gross
profit coupled with increased SG&A, including legal and
consulting expenses related to business development initiatives,
and new product development costs.
G5 Acquisition & Second Quarter Fiscal 2025 Earnings
Call
Management will host an investor conference call at 5:00 p.m. Eastern time today, Thursday, February 13, 2025, to discuss the
Company's second quarter fiscal 2025 financial results, provide a
corporate update, and conclude with Q&A from telephone
participants. To participate, please use the following
information:
Date: Thursday, February 13,
2025
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13749940
Webcast: LPTH Q2 FY2025 Earnings Conference Call
Please join at least five minutes before the start of the call
to ensure timely participation.
A playback of the call will be available through Thursday, February 27, 2025. To listen, please
call 1-844-512-2921 within the United
States and Canada or
1-412-317-6671 when calling internationally, using replay pin
number 13749940. A webcast replay will also be available using the
webcast link above.
About LightPath Technologies
LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading
provider of next-generation optics and imaging systems for both
defense and commercial applications. As a vertically integrated
solutions provider with in-house engineering design support,
LightPath's family of custom solutions range from proprietary
BlackDiamond™ chalcogenide-based glass materials – sold under
exclusive license from the U.S. Naval Research Laboratory – to
complete infrared optical systems and thermal imaging assemblies.
The Company's primary manufacturing footprint is located in
Orlando, Florida with additional
facilities in Texas, Latvia and China. To learn more, please visit
www.lightpath.com.
*Use of Non-GAAP Financial Measures
To provide investors with additional information regarding
financial results, this press release includes references to
EBITDA, which is a non-GAAP financial measure. The Company
calculates EBITDA by adjusting net income to exclude net interest
expense, income tax expense or benefit, depreciation, and
amortization.
A "non-GAAP financial measure" is generally defined as a
numerical measure of a company's historical or future performance
that excludes or includes amounts, or is subject to adjustments, so
as to be different from the most directly comparable measure
calculated and presented in accordance with GAAP. The Company's
management believes that this non-GAAP financial measure, when
considered together with the GAAP financial measure, provide
information that is useful to investors in understanding
period-over-period operating results separate and apart from items
that may, or could, have a disproportionately positive or negative
impact on results in any particular period. Management also
believes that this non-GAAP financial measure enhances the ability
of investors to analyze underlying business operations and
understand performance. In addition, management may utilize these
non-GAAP financial measures as guides in forecasting, budgeting,
and planning. Non-GAAP financial measures should be considered in
addition to, and not as a substitute for, or superior to, financial
measures presented in accordance with GAAP. A reconciliation of
these non-GAAP financial measures with the most directly comparable
financial measures calculated in accordance with GAAP is presented
in the table below.
LIGHTPATH
TECHNOLOGIES, INC.
|
Reconciliation of
Non-GAAP Financial Measures and Regulation G
Disclosure
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
Three Months Ended
December 31,
|
|
Three Months Ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net loss
|
$
(2,611,997)
|
|
$
(1,713,663)
|
|
$
(4,234,742)
|
|
$
(3,056,039)
|
Depreciation and
amortization
|
904,040
|
|
1,129,444
|
|
1,893,602
|
|
1,943,000
|
Income tax
provision
|
44,525
|
|
76,058
|
|
60,161
|
|
115,604
|
Interest
expense
|
169,053
|
|
53,788
|
|
318,413
|
|
111,399
|
|
EBITDA
|
$
(1,494,379)
|
|
$
(454,373)
|
|
$
(1,962,566)
|
|
$
(886,036)
|
|
% of revenue
|
-20 %
|
|
-6 %
|
|
-12 %
|
|
-6 %
|
Forward-Looking Statements
This press release includes statements that constitute
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by the use of words
such as "forecast," "guidance," "plan," "estimate," "will,"
"would," "project," "maintain," "intend," "expect," "anticipate,"
"prospect," "strategy," "future," "likely," "may," "should,"
"believe," "continue," "opportunity," "potential," and other
similar expressions that predict or indicate future events or
trends or that are not statements of historical matters. These
forward-looking statements are based on information available at
the time the statements are made and/or management's good faith
belief as of that time with respect to future events and are
subject to risks and uncertainties that could cause actual results
to differ materially from those expressed in or suggested by the
forward-looking statements. Factors that could cause or contribute
to such differences include, but are not limited to, the impact of
varying demand for the Company products; the ability of the Company
to obtain needed raw materials and components from its suppliers;
actions governments, businesses, and individuals take in response
to the pandemic, including restrictions on onsite commercial
interactions; general economic uncertainty in key global markets
and a worsening of global economic conditions or low levels of
economic growth; geopolitical tensions, the Russian-Ukraine
conflict, and the Hamas/ Israel
war; the effects of steps that the Company could take to reduce
operating costs; the inability of the Company to sustain profitable
sales growth, convert inventory to cash, or reduce its costs to
maintain competitive prices for its products; circumstances or
developments that may make the Company unable to implement or
realize the anticipated benefits, or that may increase the costs,
of its current and planned business initiatives; and those factors
detailed by LightPath Technologies, Inc. in its public filings with
the Securities and Exchange Commission, including its Annual Report
on Form 10-K and Quarterly Reports on 10-Q. Should one or more of
these risks, uncertainties, or facts materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those indicated or anticipated by the
forward-looking statements contained herein. Accordingly, you are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made.
Forward-looking statements should not be read as a guarantee of
future performance or results and will not necessarily be accurate
indications of the times at, or by, which such performance or
results will be achieved. Except as required under the federal
securities laws and the rules and regulations of the Securities and
Exchange Commission, we do not have any intention or obligation to
update publicly any forward-looking statements, whether as a result
of new information, future events, or otherwise.
LIGHTPATH
TECHNOLOGIES, INC.
|
Condensed
Consolidated Balance Sheets
|
(unaudited)
|
|
|
December
31,
|
|
|
June
30,
|
|
Assets
|
|
2024
|
|
|
2024
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
3,201,066
|
|
|
$
|
3,480,268
|
|
Trade accounts
receivable, net of allowance of $20,172 and $25,676
|
|
|
5,279,634
|
|
|
|
4,928,931
|
|
Inventories,
net
|
|
|
6,428,439
|
|
|
|
6,551,059
|
|
Prepaid expenses and
deposits
|
|
|
649,270
|
|
|
|
445,900
|
|
Other current
assets
|
|
|
89,891
|
|
|
|
131,177
|
|
Total current
assets
|
|
|
15,648,300
|
|
|
|
15,537,335
|
|
|
|
|
|
|
|
|
|
|
Property and equipment,
net
|
|
|
14,054,829
|
|
|
|
15,210,612
|
|
Operating lease
right-of-use assets
|
|
|
6,218,147
|
|
|
|
6,741,549
|
|
Intangible assets,
net
|
|
|
2,960,252
|
|
|
|
3,650,739
|
|
Goodwill
|
|
|
6,764,127
|
|
|
|
6,764,127
|
|
Deferred tax assets,
net
|
|
|
123,000
|
|
|
|
123,000
|
|
Other assets
|
|
|
59,536
|
|
|
|
59,602
|
|
Total
assets
|
|
$
|
45,828,191
|
|
|
$
|
48,086,964
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
3,114,382
|
|
|
$
|
3,231,713
|
|
Accrued
liabilities
|
|
|
1,448,584
|
|
|
|
1,911,867
|
|
Accrued payroll and
benefits
|
|
|
1,445,924
|
|
|
|
1,446,452
|
|
Operating lease
liabilities, current
|
|
|
997,957
|
|
|
|
1,059,998
|
|
Loans payable, current
portion
|
|
|
3,017,443
|
|
|
|
209,170
|
|
Finance lease
obligation, current portion
|
|
|
203,739
|
|
|
|
177,148
|
|
Total current
liabilities
|
|
|
10,228,029
|
|
|
|
8,036,348
|
|
|
|
|
|
|
|
|
|
|
Deferred tax
liabilities, net
|
|
|
323,402
|
|
|
|
326,197
|
|
Accrued liabilities,
noncurrent
|
|
|
315,480
|
|
|
|
611,619
|
|
Finance lease
obligation, less current portion
|
|
|
496,025
|
|
|
|
528,753
|
|
Operating lease
liabilities, noncurrent
|
|
|
7,539,488
|
|
|
|
8,058,502
|
|
Loans payable, less
current portion
|
|
|
222,829
|
|
|
|
325,880
|
|
Total
liabilities
|
|
|
19,125,253
|
|
|
|
17,887,299
|
|
|
|
|
|
|
|
|
|
|
Commitments and
Contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Preferred stock:
Series D, $.01 par value, voting; 500,000 shares authorized;
none issued and outstanding
|
|
|
—
|
|
|
|
—
|
|
Common stock:
Class A, $.01 par value, voting; 94,500,000 shares
authorized; 39,890,834 and 39,254,643 shares issued and
outstanding
|
|
|
398,908
|
|
|
|
392,546
|
|
Additional paid-in
capital
|
|
|
246,051,852
|
|
|
|
245,140,758
|
|
Accumulated other
comprehensive income
|
|
|
330,495
|
|
|
|
509,936
|
|
Accumulated
deficit
|
|
|
(220,078,317)
|
|
|
|
(215,843,575)
|
|
Total stockholders'
equity
|
|
|
26,702,938
|
|
|
|
30,199,665
|
|
Total liabilities and
stockholders' equity
|
|
$
|
45,828,191
|
|
|
$
|
48,086,964
|
|
LIGHTPATH
TECHNOLOGIES, INC.
|
Condensed
Consolidated Statements of Comprehensive Income
(Loss)
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
|
|
|
Six Months
Ended
|
|
|
|
December
31,
|
|
|
December
31,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Revenue, net
|
|
$
|
7,424,829
|
|
|
$
|
7,315,637
|
|
|
$
|
15,825,210
|
|
|
$
|
15,392,885
|
|
Cost of
sales
|
|
|
5,493,998
|
|
|
|
5,147,316
|
|
|
|
11,049,950
|
|
|
|
10,892,858
|
|
Gross
profit
|
|
|
1,930,831
|
|
|
|
2,168,321
|
|
|
|
4,775,260
|
|
|
|
4,500,027
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative
|
|
|
3,356,063
|
|
|
|
2,858,457
|
|
|
|
6,626,646
|
|
|
|
5,519,625
|
|
New product
development
|
|
|
764,396
|
|
|
|
607,747
|
|
|
|
1,240,837
|
|
|
|
1,247,636
|
|
Amortization of
intangible assets
|
|
|
294,711
|
|
|
|
485,446
|
|
|
|
690,487
|
|
|
|
766,717
|
|
Loss on disposal of
property and equipment
|
|
|
—
|
|
|
|
—
|
|
|
|
78,437
|
|
|
|
—
|
|
Total operating
expenses
|
|
|
4,415,170
|
|
|
|
3,951,650
|
|
|
|
8,636,407
|
|
|
|
7,533,978
|
|
Operating
loss
|
|
|
(2,484,339)
|
|
|
|
(1,783,329)
|
|
|
|
(3,861,147)
|
|
|
|
(3,033,951)
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense,
net
|
|
|
(169,053)
|
|
|
|
(53,788)
|
|
|
|
(318,413)
|
|
|
|
(111,399)
|
|
Other income,
net
|
|
|
85,920
|
|
|
|
199,512
|
|
|
|
4,979
|
|
|
|
204,915
|
|
Total other expense,
net
|
|
|
(83,133)
|
|
|
|
145,724
|
|
|
|
(313,434)
|
|
|
|
93,516
|
|
Loss before income
taxes
|
|
|
(2,567,472)
|
|
|
|
(1,637,605)
|
|
|
|
(4,174,581)
|
|
|
|
(2,940,435)
|
|
Income tax
provision
|
|
|
44,525
|
|
|
|
76,058
|
|
|
|
60,161
|
|
|
|
115,604
|
|
Net loss
|
|
$
|
(2,611,997)
|
|
|
$
|
(1,713,663)
|
|
|
$
|
(4,234,742)
|
|
|
$
|
(3,056,039)
|
|
Foreign currency
translation adjustment
|
|
|
(451,035)
|
|
|
|
259,973
|
|
|
|
(179,441)
|
|
|
|
134,765
|
|
Comprehensive
loss
|
|
$
|
(3,063,032)
|
|
|
$
|
(1,453,690)
|
|
|
$
|
(4,414,183)
|
|
|
$
|
(2,921,274)
|
|
Loss per common share
(basic)
|
|
$
|
(0.07)
|
|
|
$
|
(0.05)
|
|
|
$
|
(0.11)
|
|
|
$
|
(0.08)
|
|
Number of shares used
in per share calculation
(basic)
|
|
|
39,728,933
|
|
|
|
37,501,683
|
|
|
|
39,645,206
|
|
|
|
37,466,714
|
|
Loss per common share
(diluted)
|
|
$
|
(0.07)
|
|
|
$
|
(0.05)
|
|
|
$
|
(0.11)
|
|
|
$
|
(0.08)
|
|
Number of shares used
in per share calculation
(diluted)
|
|
|
39,728,933
|
|
|
|
37,501,683
|
|
|
|
39,645,206
|
|
|
|
37,466,714
|
|
LIGHTPATH
TECHNOLOGIES, INC.
|
Condensed
Consolidated Statements of Changes in Stockholders'
Equity
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
Class
A
|
|
|
Additional
|
|
|
Other
|
|
|
|
|
|
Total
|
|
|
|
Common
Stock
|
|
|
Paid-in
|
|
|
Comphrehensive
|
|
|
Accumulated
|
|
|
Stockholders'
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Income
|
|
|
Deficit
|
|
|
Equity
|
|
Balances at
June 30, 2024
|
|
|
39,254,643
|
|
|
$
|
392,546
|
|
|
$
|
245,140,758
|
|
|
$
|
509,936
|
|
|
$
|
(215,843,575)
|
|
|
$
|
30,199,665
|
|
Issuance of
common stock
for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
Stock Purchase
Plan
|
|
|
8,232
|
|
|
|
82
|
|
|
|
10,290
|
|
|
|
—
|
|
|
|
—
|
|
|
|
10,372
|
|
Exercise of
Stock Options,
RSUs & RSAs,
net
|
|
|
70,309
|
|
|
|
703
|
|
|
|
(703)
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Issuance of
common stock
for acquisition
of Visimid
|
|
|
279,553
|
|
|
|
2,796
|
|
|
|
318,562
|
|
|
|
—
|
|
|
|
—
|
|
|
|
321,358
|
|
Stock-based
compensation
on stock
options, RSUs
& RSAs
|
|
|
—
|
|
|
|
—
|
|
|
|
264,475
|
|
|
|
—
|
|
|
|
—
|
|
|
|
264,475
|
|
Foreign
currency
translation
adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
271,594
|
|
|
|
—
|
|
|
|
271,594
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,622,745)
|
|
|
|
(1,622,745)
|
|
Balances at
September 30,
2024
|
|
|
39,612,737
|
|
|
$
|
396,127
|
|
|
$
|
245,733,382
|
|
|
$
|
781,530
|
|
|
$
|
(217,466,320)
|
|
|
$
|
29,444,719
|
|
Issuance of
common stock
for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of
Stock Options,
RSUs & RSAs,
net
|
|
|
229,097
|
|
|
|
2,291
|
|
|
|
(2,291)
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Shares issued as
compensation
|
|
|
49,000
|
|
|
|
490
|
|
|
|
89,180
|
|
|
|
—
|
|
|
|
—
|
|
|
|
89,670
|
|
Stock-based
compensation
on stock
options, RSUs
& RSAs
|
|
|
—
|
|
|
|
—
|
|
|
|
231,581
|
|
|
|
—
|
|
|
|
—
|
|
|
|
231,581
|
|
Foreign
currency
translation
adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(451,035)
|
|
|
|
—
|
|
|
|
(451,035)
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(2,611,997)
|
|
|
|
(2,611,997)
|
|
Balances at
December 31,
2024
|
|
|
39,890,834
|
|
|
$
|
398,908
|
|
|
$
|
246,051,852
|
|
|
$
|
330,495
|
|
|
$
|
(220,078,317)
|
|
|
$
|
26,702,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at
June 30, 2023
|
|
|
37,344,739
|
|
|
$
|
373,447
|
|
|
$
|
242,808,771
|
|
|
$
|
606,536
|
|
|
$
|
(207,836,229)
|
|
|
$
|
35,952,525
|
|
Issuance of
common stock
for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
Stock Purchase
Plan
|
|
|
14,607
|
|
|
|
146
|
|
|
|
19,573
|
|
|
|
—
|
|
|
|
—
|
|
|
|
19,719
|
|
Exercise of
Stock Options,
RSUs & RSAs,
net
|
|
|
14,482
|
|
|
|
145
|
|
|
|
(145)
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Issuance of
common stock
for acquisition
of Visimid
|
|
|
81,610
|
|
|
|
816
|
|
|
|
149,184
|
|
|
|
—
|
|
|
|
—
|
|
|
|
150,000
|
|
Stock-based
compensation
on stock
options, RSUs
& RSAs
|
|
|
—
|
|
|
|
—
|
|
|
|
240,075
|
|
|
|
—
|
|
|
|
—
|
|
|
|
240,075
|
|
Foreign
currency
translation
adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(125,208)
|
|
|
|
—
|
|
|
|
(125,208)
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,342,376)
|
|
|
|
(1,342,376)
|
|
Balances at
September 30,
2023
|
|
|
37,455,438
|
|
|
$
|
374,554
|
|
|
$
|
243,217,458
|
|
|
$
|
481,328
|
|
|
$
|
(209,178,605)
|
|
|
$
|
34,894,735
|
|
Issuance of
common stock
for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of
Stock Options,
RSUs & RSAs,
net
|
|
|
93,940
|
|
|
|
940
|
|
|
|
(940)
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Stock-based
compensation
on stock
options, RSUs
& RSAs
|
|
|
—
|
|
|
|
—
|
|
|
|
258,691
|
|
|
|
—
|
|
|
|
—
|
|
|
|
258,691
|
|
Foreign
currency
translation
adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
259,973
|
|
|
|
—
|
|
|
|
259,973
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,713,663)
|
|
|
|
(1,713,663)
|
|
Balances at
December 31,
2023
|
|
|
37,549,378
|
|
|
$
|
375,494
|
|
|
$
|
243,475,209
|
|
|
$
|
741,301
|
|
|
$
|
(210,892,268)
|
|
|
$
|
33,699,736
|
|
LIGHTPATH
TECHNOLOGIES, INC.
|
Condensed
Consolidated Statements of Cash Flows
|
(unaudited)
|
|
|
Six Months Ended
December 31,
|
|
|
|
2024
|
|
|
2023
|
|
Cash flows from
operating activities:
|
|
|
|
|
|
|
Net loss
|
|
$
|
(4,234,742)
|
|
|
$
|
(3,056,039)
|
|
Adjustments to
reconcile net loss to net cash (used in) provided by operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
1,893,602
|
|
|
|
1,943,000
|
|
Interest from
amortization of loan issuance costs
|
|
|
120,833
|
|
|
|
—
|
|
Loss on disposal of
property and equipment
|
|
|
78,437
|
|
|
|
—
|
|
Stock-based
compensation on stock options, RSUs & RSAs, net
|
|
|
506,020
|
|
|
|
551,853
|
|
Provision for credit
losses
|
|
|
—
|
|
|
|
(2,236)
|
|
Change in operating
lease assets and liabilities
|
|
|
(57,653)
|
|
|
|
80,355
|
|
Inventory write-offs
to allowance
|
|
|
135,625
|
|
|
|
73,569
|
|
Deferred
taxes
|
|
|
(2,795)
|
|
|
|
9,395
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
Trade accounts
receivable
|
|
|
(350,703)
|
|
|
|
1,717,283
|
|
Other current
assets
|
|
|
41,286
|
|
|
|
(191,381)
|
|
Inventories
|
|
|
(13,005)
|
|
|
|
54,461
|
|
Prepaid expenses and
deposits
|
|
|
(123,598)
|
|
|
|
94,619
|
|
Accounts payable and
accrued liabilities
|
|
|
(430,923)
|
|
|
|
(424,310)
|
|
Net cash (used in)
provided by operating activities
|
|
|
(2,437,616)
|
|
|
|
850,569
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
Purchase of property
and equipment
|
|
|
(160,155)
|
|
|
|
(1,484,401)
|
|
Proceeds from sale of
equipment
|
|
|
10,648
|
|
|
|
—
|
|
Proceeds from
sale-leaseback of equipment
|
|
|
—
|
|
|
|
364,710
|
|
Acquisition of
Visimid, net of cash acquired
|
|
|
—
|
|
|
|
(722,141)
|
|
Net cash used in
investing activities
|
|
|
(149,507)
|
|
|
|
(1,841,832)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from sale of
common stock from Employee Stock Purchase Plan
|
|
|
10,372
|
|
|
|
19,719
|
|
Deferred payment for
acquisition of Visimid
|
|
|
(125,000)
|
|
|
|
—
|
|
Loan issuance
costs
|
|
|
(300,000)
|
|
|
|
—
|
|
Borrowings on loans
payable
|
|
|
3,000,000
|
|
|
|
142,853
|
|
Payments on loans
payable
|
|
|
(106,486)
|
|
|
|
(407,510)
|
|
Repayment of finance
lease obligations
|
|
|
(89,705)
|
|
|
|
(58,785)
|
|
Net cash provided by
(used in) financing activities
|
|
|
2,389,181
|
|
|
|
(303,723)
|
|
Effect of exchange rate
on cash and cash equivalents
|
|
|
(81,260)
|
|
|
|
32,698
|
|
Change in cash, cash
equivalents and restricted cash
|
|
|
(279,202)
|
|
|
|
(1,262,288)
|
|
Cash, cash equivalents
and restricted cash, beginning of period
|
|
|
3,480,268
|
|
|
|
7,144,490
|
|
Cash, cash equivalents
and restricted cash, end of period
|
|
$
|
3,201,066
|
|
|
$
|
5,882,202
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure
of cash flow information:
|
|
|
|
|
|
|
|
|
Interest paid in
cash
|
|
$
|
40,838
|
|
|
$
|
110,774
|
|
Income taxes
paid
|
|
$
|
61,427
|
|
|
$
|
114,953
|
|
Supplemental disclosure
of non-cash investing & financing activities:
|
|
|
|
|
|
|
|
|
Purchase of equipment
through finance lease arrangements
|
|
$
|
93,048
|
|
|
$
|
61,654
|
|
Issuance of common
stock for acquisition of Visimid
|
|
$
|
321,358
|
|
|
$
|
150,000
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lightpath-technologies-reports-second-quarter-fiscal-2025-financial-results-302375943.html
SOURCE LightPath Technologies